Nancy C. Brahm

687 total citations
50 papers, 436 citations indexed

About

Nancy C. Brahm is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Nancy C. Brahm has authored 50 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 13 papers in Pediatrics, Perinatology and Child Health and 9 papers in Pharmacology. Recurrent topics in Nancy C. Brahm's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Schizophrenia research and treatment (8 papers) and Pharmaceutical studies and practices (7 papers). Nancy C. Brahm is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Schizophrenia research and treatment (8 papers) and Pharmaceutical studies and practices (7 papers). Nancy C. Brahm collaborates with scholars based in United States. Nancy C. Brahm's co-authors include Mark D. Fox, Kevin C. Farmer, Julie C. Kissack, Robert C. Brown, Jerry McKee, Ricky T. Muñoz, David A. McLeod, Michael J. Miller, Barbara R. Neas and Donald L. Harrison and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Pharmacotherapy and American Journal of Health-System Pharmacy.

In The Last Decade

Nancy C. Brahm

48 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy C. Brahm United States 11 119 72 67 67 65 50 436
Keith Flower United States 10 81 0.7× 62 0.9× 50 0.7× 54 0.8× 143 2.2× 10 340
Rachel Meyer United States 9 127 1.1× 71 1.0× 77 1.1× 61 0.9× 314 4.8× 13 791
Anthony Glasper United Kingdom 10 74 0.6× 57 0.8× 85 1.3× 106 1.6× 62 1.0× 11 385
Albrecht Eisert Germany 17 75 0.6× 63 0.9× 26 0.4× 44 0.7× 82 1.3× 53 609
Jon Mordal Norway 10 140 1.2× 102 1.4× 72 1.1× 33 0.5× 51 0.8× 22 352
Emanuela Trogu Italy 13 161 1.4× 114 1.6× 31 0.5× 125 1.9× 148 2.3× 19 545
Michael Specka Germany 16 172 1.4× 129 1.8× 68 1.0× 183 2.7× 104 1.6× 71 718
Maria C. Catalano United States 16 269 2.3× 146 2.0× 33 0.5× 40 0.6× 60 0.9× 52 755
Michael J. Mancino United States 15 76 0.6× 101 1.4× 37 0.6× 199 3.0× 148 2.3× 40 659
Debasish Basu India 14 143 1.2× 97 1.3× 39 0.6× 48 0.7× 46 0.7× 41 466

Countries citing papers authored by Nancy C. Brahm

Since Specialization
Citations

This map shows the geographic impact of Nancy C. Brahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy C. Brahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy C. Brahm more than expected).

Fields of papers citing papers by Nancy C. Brahm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy C. Brahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy C. Brahm. The network helps show where Nancy C. Brahm may publish in the future.

Co-authorship network of co-authors of Nancy C. Brahm

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy C. Brahm. A scholar is included among the top collaborators of Nancy C. Brahm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy C. Brahm. Nancy C. Brahm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brahm, Nancy C., et al.. (2017). Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician. 7(4). 156–159. 4 indexed citations
2.
Brahm, Nancy C., et al.. (2017). Genital Somatic Complaints in a Woman with Schizoaffective Disorder. Psychiatric Annals. 47(2). 69–71.
3.
Farmer, Kevin C., et al.. (2016). Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression. International Journal of Clinical Pharmacy. 38(2). 429–437. 9 indexed citations
4.
5.
Mittal, Manish, Donald L. Harrison, Michael J. Miller, & Nancy C. Brahm. (2013). National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning. Research in Social and Administrative Pharmacy. 10(5). 781–790. 11 indexed citations
6.
Brahm, Nancy C., et al.. (2013). Acceptance Rates for Pharmacist-Initiated Interventions in Long-Term Care Facilities. SHILAP Revista de lepidopterología. 4(4). 7 indexed citations
7.
Brahm, Nancy C., et al.. (2013). A Case of Seizure Activity Associated With a Therapeutic Dose of Venlafaxine. The Primary Care Companion For CNS Disorders. 15(1). 2 indexed citations
8.
Brahm, Nancy C., et al.. (2012). Which Psychotropics Carry the Greatest Risk of QTc Prolongation. Current psychiatry. 11(10). 36. 3 indexed citations
9.
Farmer, Kevin C., et al.. (2012). Evaluation of Serum Prolactin Levels in Intellectually Disabled Patients Using Antipsychotic Medications. International Journal of Endocrinology and Metabolism. 11(1). 57–61. 4 indexed citations
10.
Brahm, Nancy C., et al.. (2011). Hypomania Secondary to a Change in Altitude in an Adolescent Male. Clinical Schizophrenia & Related Psychoses. 5(2). 102–105. 2 indexed citations
11.
Brahm, Nancy C., et al.. (2011). Antidepressant-Mediated Gastroesophageal Reflux Disease. The Consultant Pharmacist. 26(4). 274–278. 6 indexed citations
12.
Brahm, Nancy C., et al.. (2011). Violence among persons diagnosed with schizophrenia: How pharmacists can help. Research in Social and Administrative Pharmacy. 7(4). 421–429. 2 indexed citations
13.
Brahm, Nancy C. & Kevin C. Farmer. (2010). A student practice experience focusing on the intellectually disabled. Currents in Pharmacy Teaching and Learning. 2(3). 138–143. 2 indexed citations
14.
Brahm, Nancy C., et al.. (2009). Recurrent Episodes of Serotonin-Reuptake Inhibitor- Mediated Hyponatremia in an Elderly Patient. The Consultant Pharmacist. 24(10). 765–768. 17 indexed citations
15.
Brahm, Nancy C., et al.. (2009). Collaboration: What can health-care organizations learn about pharmacist retention from Magnet status hospitals?. Research in Social and Administrative Pharmacy. 5(4). 382–389. 2 indexed citations
16.
Brahm, Nancy C., et al.. (2009). Alopecia Following Initiation of Lisdexamfetamine in a Pediatric Patient. The Primary Care Companion to The Journal of Clinical Psychiatry. 11(6). 365–365. 9 indexed citations
17.
Brahm, Nancy C., et al.. (2008). Exacerbation of Psychosis: A Case of Possible Varenicline-Mediated Effects in an Intellectually Disabled Adult. Clinical Schizophrenia & Related Psychoses. 2(3). 259–261. 1 indexed citations
18.
Brahm, Nancy C., et al.. (2007). Bedlam Community Health Clinic: A collaborative interdisciplinary health care service for the medically indigent. Journal of the American Pharmacists Association. 47(3). 398–403. 7 indexed citations
19.
Brahm, Nancy C., Kevin C. Farmer, & Robert C. Brown. (2007). Risperidone for the treatment of fecal smearing in a developmentally disabled adult. American Journal of Health-System Pharmacy. 64(4). 382–384. 3 indexed citations
20.
Brahm, Nancy C., et al.. (2007). Risperidone and Dysphagia in a Developmentally Disable Woman. The Primary Care Companion to The Journal of Clinical Psychiatry. 9(4). 315–316. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Flower Breakdown of academic impact, for papers by Rachel Meyer Breakdown of academic impact, for papers by Anthony Glasper Breakdown of academic impact, for papers by Albrecht Eisert Breakdown of academic impact, for papers by Jon Mordal Breakdown of academic impact, for papers by Emanuela Trogu Breakdown of academic impact, for papers by Michael Specka Breakdown of academic impact, for papers by Maria C. Catalano Breakdown of academic impact, for papers by Michael J. Mancino Breakdown of academic impact, for papers by Debasish Basu
Rankless by CCL
2026